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Abstract: For tissue engineered bone constructs, calcium
phosphate cement (CPC) has a high potential as scaffold
material because of its biocompatibility and osteoconduc-
tivity. However, in vivo resorption and tissue ingrowth is
slow. To address these issues, microspheres can be incor-
porated into the cement, which will create macroporosity
after in situ degradation. The goal of this study was to
investigate the handling properties and degradation char-
acteristics of CPC containing gelatin microspheres. Setting
time and injectability were determined and an in vitro deg-
radation study was performed. Samples were assayed on
mass, compression strength, E-modulus, and morphology.
A supplementary degradation test with gelatin micro-
spheres was performed to investigate the influence of
physical conditions inside the cement on microsphere sta-
bility. The gelatin microsphere CPCs were easy to inject
and showed initial setting times of less than 3 min. After
12-weeks in vitro degradation no increase in macroporosity
was observed, which was supported by the small mass
loss and stabilizing mechanical strength. Even a clear den-
sification of the composite was observed. Explanations for
the lack of macroporosity were recrystallization of the
cement onto or inside the gelatin spheres and a delayed
degradation of gelatin microspheres inside the scaffold.
The supplementary degradation test showed that the pH is
a factor in the delayed gelatin microsphere degradation.
Also differences in degradation rate between types of gela-
tin were observed. Overall, the introduction of gelatin
microspheres into CPC renders composites with good han-
dling properties, though the degradation characteristics
should be further investigated to generate a macroporous
scaffold.  2008 Wiley Periodicals, Inc. J Biomed Mater
Res 87A: 643–655, 2008
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INTRODUCTION
Bone defects caused by trauma or tumor resection
and age related loss of bone mass induce a high
demand for bone filling materials. Most synthetic
alloplasts are not suitable for these types of applica-
tions because their mechanical/physical or biological
properties are not sufficient, so in most cases autoge-
nous bone is still used.1,2 On the other hand, calcium
phosphate compounds appear to be an attractive al-
ternative, as they are osteoconductive and can reach
to compression strengths that are comparable to
bone.3 Especially calcium phosphate cement (CPC) is
a good candidate since it can be shaped to the defect
site after injection and renders an optimal contact
between bone and material.4 Despite this, the in vivo
resorption and tissue ingrowth of most CPCs is
slow.5 In previous studies6–8 poly(DL-lactic-co-glycolic
acid) (PLGA) microspheres were added to improve
the properties of a CPC for tissue engineering pur-
poses. These microspheres introduced macroporosity
into the cement and were also applied for the deliv-
ery of growth factors. In vitro degradation tests6
showed a slow degradation of the PLGA micro-
spheres that was accompanied by a pH decrease of
the surrounding medium. Compressive strength of
the microsphere composites decreased concomitantly
as the PLGA eroded, rendering highly macroporous
scaffolds.
Next to PLGA other polymers can also be applied
for the production of microspheres. Especially natu-
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ral polymers like chitosan,9 collagen,10,11 and gelatin
are interesting candidates that demonstrate enzy-
matic degradation. Of these polymers, gelatin would
be the preferred material because it does not express
antigenicity in physiological conditions and is com-
pletely resorbable in vivo, unlike collagen.12 Gelatin
microspheres have been used by different authors
for the sustained release of growth factors.13,14 Here,
the loading of growth factor relies on an ion-binding
interaction between an acidic or basic gelatin and a
positively/negatively charged protein.15 To stabilize
gelatin microspheres in an aqueous environment a
crosslinker16–18 is used. Degradation characteristics
of the microspheres can be tailored by changing the
crosslinking density. Gelatin can be derived from
different animal sources, though porcine (type A, ba-
sic) and bovine (type B, acidic) gelatin cover 95% of
both household and industrial use. Food grade (FG)
gelatin consists mostly of type A gelatin (80%) and
less of type B (15%).
The goal of this study was to characterize the gela-
tin microsphere CPC on mechanical/ physical prop-
erties and degradation characteristics. For this pur-
pose, FG gelatin microspheres with different cross-
linking densities were incorporated into the cement.
Injectability and setting/cohesive properties of the
composites were determined. Furthermore, a 12-
week in vitro degradation test in proteolytic medium
was performed using preset scaffolds. Samples were
assayed on mass loss, compressive strength, E-mod-
ulus, and morphology. In addition to the in vitro
degradation test, a degradation study with gelatin
microspheres was performed to investigate the influ-
ence of physical conditions inside the cement like
pH and calcium concentration on microsphere stabil-
ity. Also degradation characteristics of type A and
type B gelatin microspheres were compared to the
FG gelatin.
MATERIALS AND METHODS
Materials
Gelatin (FG, Granules, pH 5 3.8–7.6, bloom number 5
80–120, Merck, Darmstadt, Germany; type A (pI 5 7.0–9.0,
bloom number 5 300)/type B (pI 5 4.7–5.2, bloom number
5 225), cell culture tested, Sigma-Aldrich, St. Louis, MO)
was used for the preparation of the microspheres. Olive oil
(Acros Organics, Geel, Belgium) and acetone (HPLC grade,
Labscan, Dublin, Ireland) were used as substrate during
microsphere preparation. Glutaraldehyde (25 wt % solu-
tion, EM-grade, Merck, Darmstadt, Germany) was applied
as crosslinker. The CPC (Calcibon1, Biomet Merck, Darm-
stadt, Germany) was composed of 61% a-TCP, 26%
CaHPO4, 10% CaCO3, and 3% precipitated HA. The cement
liquid applied was a 1% aqueous solution of Na2HPO4.
Methods
Preparation of gelatin microspheres
2.5 g of gelatin was dissolved in 25 mL demineralized
water (ddH2O) for 30 min at 608C. While stirring at 500
rpm using a Teflon upper stirrer, the resulting clear solu-
tion was added slowly (10 mL pipette) to a 250-mL three-
necked round-bottom flask containing 125 mL olive oil.
During stirring, the round bottom flask was put in an ice
bath. After 30 min, 50 mL of chilled acetone (48C) and glu-
taraldehyde (0.5 mL 5 6.25 mM) was added slowly. The
solution was stirred for another 1 h (GEL1) or 2 h (GEL2)
to produce microspheres with a higher extent of crosslink-
ing. Microspheres were collected by filtration (D3, Schott
Duran, Mainz, Germany) and washed several times with
acetone (1l) to remove residual olive oil. Following this,
microspheres were dried over night in a vacuum stove.
For the enhanced degradation test all microspheres were
crosslinked for 1 h.
Preparation of gelatin microsphere CPC
Gelatin microspheres were swollen before cement pow-
der or liquid hardener was added to obtain a good distri-
bution of microspheres inside the cement. Therefore, 50 mg
of dried GEL1/GEL2 microspheres were put in a 2-mL
plastic syringe, subsequently adding 300 lL/250 lL
ddH2O after which the syringe was stirred vigorously for
15 s using a mixing device (Silamat1 mixing apparatus,
Vivadent, Schaan, Liechtenstein). Subsequently, 950 mg
cement powder was added to the swollen microspheres
and the resulting mixture was stirred for another 15 s.
Then 300 lL of hardener solution (1% Na2HPO4) was
added and the content was stirred again for 15 s. The
resulting cement paste was injected into a Teflon mold (six
cylinders, 4.5 mm 3 10 mm), after which samples were
left to set at room temperature for 24 h and stored in a
vacuum stove.
Morphology analysis
The morphology of the gelatin microspheres and gela-
tin microsphere CPC was evaluated by scanning electron
microscopy (SEM) (JEOL 6400-LINK AN 10000 at 10 kV).
The samples were mounted on aluminum stubs using
carbon tape and sputter-coated with gold-palladium before
examination.
Size distribution
The particle size distribution of the gelatin microspheres
was determined by image analysis. Dry microspheres were
visualized by SEM, while swollen microspheres were char-
acterized with an optical microscope (Leica) after suspen-
sion in ddH2O. The size distribution of both dry and swol-
len spheres was determined using digital image software
(Leica Qwin).
644 HABRAKEN ET AL.
Journal of Biomedical Materials Research Part A
Injectability
After mixing, the syringe, with an orifice diameter of
1.7 mm, was fitted vertically in a fixture and put under the
platen of a tensile bench set (858 MiniBionixII1, MTS
Corp., Eden Prairie, MN) in tension mode.6 The cement
composites were compressed until 1 cc was present
inside the syringes, which was used as starting point.
Twenty-five seconds after mixing the cement (for 15 s), a
compressive force was applied to the syringe with a con-
stant velocity of 10 mm/min. The compressive force was
recorded as a function of the plunger travel length19 after
which it was converted into time. The time from mixing
the paste until pressure reaches 60 N, is referred to as the
injection time. If all the paste is injected before pressure
increase, the paste is regarded as fully injectable. All tests
were performed threefold (n 5 3).
Setting time
The initial and final setting times were assessed using
custom available Gillmore needles (ASTM C266). A bronze
block was used as mold containing six holes (6 mm in di-
ameter, 12 mm in height). The mold was placed in a water
bath to simulate body temperature (378C). Samples were
mixed and injected into the mold in a retrograde fashion,
after which the initial and final setting time of the samples
was determined (n 5 3).
For determination of the cohesive properties of the gela-
tin microsphere CPC, samples were injected into Ringer’s
solution at 378C. During the cement setting time it was
observed whether the paste retained its original configura-
tion or powder formation/disintegration occurred. Every
anomaly was recorded.
Porosity
The macro- and total-porosity of preset gelatin micro-
sphere CPC samples was determined. The macroporosity
is the porosity in which the pores are created by the degra-
dation of gelatin microspheres. The total porosity is the
macroporosity plus the original microporosity of the
cement. When the gelatin microspheres are not degraded,
the macroporosity correspond to the vol % of microspheres
initially present inside the cement.
To measure these parameters, both gelatin microsphere
CPC samples and microporous CPC samples of a known
volume were placed in an oven at 6508C for 2 h. After
burning out the gelatin/moisture, samples were weighed
and Eqs. (1) and (2) were used for the derivation of the
total porosity and the macroporosity. Tests were per-
formed threefold (n 5 3).
etot ¼ 1
mmacro=micro
V 3 qHAP
 
3 100% ð1Þ
emacro ¼ 1mmacro
mmicro
 
3 100% ð2Þ
where etot 5 total porosity (%), emacro 5 macroporosity
(%), mmacro 5 average mass macroporous sample (after
burning out gelatin) (g, n 5 3), mmicro 5 average mass
microporous sample (g, n 5 3), V 5 volume sample (cm3),
qHAP 5 density hydroxy apatite (g/cm
3).
Degradation assay
For the degradation assay gelatin microsphere CPC sam-
ples were prepared as described earlier. Samples were
placed in 3 mL of phosphate-buffered saline (PBS, pH 7.4)
containing 50 lg/mL gentamycin and 373 ng/mL collage-
nase 1A(Sigma)13 and incubated at 378C in a water bath on
a shaker table (70 rpm) for 12 weeks. Every 3–4 days sam-
ple buffer was refreshed. At days 1, 3, 7, 14, 28, 42, and 84,
specimens were subjected to analysis according to the
descriptions summarized later. Samples were taken five-
fold (n 5 5). Gelatin microspheres (8–9 mg, dry spheres)
and microporous cement scaffolds were used as a control.
pH measurements
After removal of the samples from the water bath the
pH of the PBS medium was measured.
Mass loss quantification
Samples were freeze-dried overnight before measuring
the mass. The mass loss of the samples was calculated
using Eq. (3).
RL ¼ M0 Mn
M0
3 100% ð3Þ
where RL 5 mass loss sample at t 5 n (%), M0 5 Mass
sample at t 5 0 (g), Mn 5 Mass sample at t 5 n (g).
Morphology
The morphology of the samples was determined using
SEM. To visualize composite degradation and increase in
(macro)porosity, overview pictures were taken at a magni-
fication of 3 100. Also, pictures were taken at higher mag-
nifications to visualize the microsphere degradation. Next
to that, energy dispersive X-ray spectrometry (EDS) was
performed for further material analysis.
Mechanical characteristics
Samples were placed in a mechanical testing bench (858
MiniBionixII1, MTS Corp., Eden Prairie, MN) and both
compressive strength and E-modulus along the height
of the specimens were measured at a crosshead speed of
0.5 mm/min.
Supplementary microsphere degradation study
In addition to the 12-weeks degradation study, a degrada-
tion study using gelatin microspheres was performed to
investigate the influence of physical conditions inside the
cement like pH and calcium concentration on microsphere
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stability. Also, the degradation characteristics of FG gelatin
microspheres were compared to microspheres of type A and
type B gelatin. In this study the degradation of the micro-
spheres was enhanced by applying a high concentration of
gelatin-degrading enzyme, which enabled us to compare the
degradation characteristics of these microspheres within a
short time period. For this purpose 10 mg of 1 h crosslinked
gelatin microspheres of either type A, B, or FG were put in
3 mL PBS containing 10 lg/mL collagenase 1A at 378C.
Applying these conditions, a pilot study showed that FG
microspheres were fully degraded within 3 days. Because an
exponential degradation profile was observed in this pilot, a
time period of 1 day was chosen for the degradation study.
To mimic the conditions inside the gelatin microsphere
CPCs, gelatin microspheres were pretreated for 1 day in PBS
containing 0.1M CaCl2 (pH5 5.72) before they were exposed
to the enhanced degradation medium. PBS (pH 5 7.4) and
acidic PBS (pH 5 5.72) were taken as a control. Samples
were assayed on mass loss and morphology (n5 3).
Statistical analysis
Data were arranged as mean 6 standard deviation. Sig-
nificant differences were determined using analysis of var-
iance (ANOVA). Results were considered significant if p <
0.05. Calculations were performed using GraphPad Instat1.
RESULTS
Preparation of microspheres
SEM-micrographs of the prepared microspheres
are shown in Figure 1(A,B). Dry microspheres were
partially agglomerated and imprints of the intercon-
nections between the spheres were visible at the sur-
face. In an aqueous environment, the GEL1 and
GEL2 microspheres showed 1.5 times increase in
diameter (Table I) during which the interconnections
were broken. The size distribution [Fig. 1(C)] showed
that most unswollen microspheres were below 10 lm
in diameter and an increase in sphere size higher than
30 lm was observed after swelling. Overall, a slightly
higher percentage of larger spheres was observed in
the GEL1 group.
Preparation and clinical handling properties
of gelatin microsphere CPC
A SEM-micrograph of the microspheres inside the
cement is given in Figure 2 (A), which is representa-
tive for both GEL1 and GEL2 microsphere CPCs. A
Figure 1. SEM images of the morphology of GEL1 microspheres (A), GEL2 microspheres (B), and size distribution of dry
and swollen microspheres (C), group size: n 5 171/166 (dry microspheres), n 5 201/222 (swollen microspheres).
TABLE I
Physical Parameters Cement/Microsphere Formulations
Microporous6 GEL1 CPC GEL2 CPC
Average microsphere size (lm) – 9.70 (dry) 8.64 (dry)
14.79 (swollen) 13.76 (swollen)
Initial setting time (s) 108.3 6 5.8 165.0 6 15.0 145.0 6 8.7
Injection time (s) 108 128 120
Mass (mg) 262.7 6 6.1 166.0 6 5.3 174.2 6 5.5
Porositya 45.52 6 1.26 69.67 6 1.29 69.21 6 0.36
Macro porositya – 44.32 43.49
aAfter removing gelatin microspheres.
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substantial percentage of the spheres was broken,
showing an eggshell structure. Furthermore, an equal
distribution of microspheres inside the cement was
obtained.
The injectability graph of the gelatin microsphere
CPCs [Fig. 2(B)] showed that the pressure on the sy-
ringe increased at a later time point than the micropo-
rous cement,6 indicating that the composite cement
was easier to inject. When comparing both gelatin
microsphere CPCs, the GEL1 composite showed a lon-
ger injection time, that is, better injectability than the
GEL2 composite. The setting time (Table I) of both
gelatin microsphere CPCs was comparable to each
other and slightly higher than the microporous
cement (p < 0.01). No final setting time was meas-
ured due to the high water content of the gelatin
microspheres. Cohesion tests revealed no powder
formation or disintegration when injecting the sam-
ples in an aqueous environment. The macroporosity
of both GEL1 and GEL2 microsphere CPCs was 43–
44%, with a total porosity of 69–70%.
Degradation assay
In Figure 3 (A) the cumulative pH of the PBS me-
dium is given as a function of the degradation time.
The medium of both gelatin microsphere CPCs
showed an initial pH increase, followed by a
decrease and stabilized at a pH of 6.1 at t 5 40 days.
The release medium of both GEL1 and GEL2 micro-
spheres showed a small decrease at a pH of 7.1.
The development of the mass in time is shown in
Figure 3(B). For both gelatin microsphere CPCs an
initial increase of 2% was followed by a slow
decrease in mass. After 12 weeks a maximum
decrease of 2% was observed. The microporous
cement only showed an increase in mass of 3% that
appeared to decrease after 12 weeks. Significant dif-
ferences in mass loss between the microporous
cement and gelatin microsphere CPCs were ob-
served (p < 0.05 at t 5 4, 8 weeks), though only the
GEL1 microsphere CPC showed a significant
decrease in mass at t 5 12 weeks (p < 0.01). The gel-
atin microspheres showed an initial increase in mass
that was higher than the increase of the gelatin
microsphere CPCs, but decreased very rapidly after
3 days. Significant differences between the GEL1 and
GEL2 microspheres were observed at day 1 and 14
(p < 0.05), although the trend was similar. The de-
velopment of the compression strength of the gelatin
microsphere CPCs over time is given in Figure 4
(A). An initial increase was observed over 7 days, af-
ter which the compression strength remained almost
constant for 12 weeks. The final compression strength
of both gelatin microsphere CPCs was 30 MPa, which
was significantly lower than the microporous cement
(p < 0.001). The E-modulus [Fig. 4(B)] showed a
comparable trend with respect to the compression
strength with an increase till day 7 after which it
remained stable at 6 2000 MPa. Also here the micro-
porous cement was significantly higher (p < 0.05)
and no significant differences were observed be-
tween the GEL1 and GEL2 composites.
The morphology of the gelatin microsphere CPCs
and gelatin microspheres separately are given in Fig-
ures 5 and 6. For both gelatin microsphere CPCs
small differences in morphology were observed
between samples from day 1 to week 12. Micro-
sphere structures were still visible after 12 weeks
and no increase in macroporosity was observed dur-
ing the degradation test. In contrast, comparison of
samples taken at day 1 with samples taken at later
time points showed even a clear densification of the
material. At higher magnifications (Fig. 7), the pres-
ence of crystals onto/inside the gelatin microspheres
Figure 2. Morphology of gelatin microsphere CPC (A) and injectability graph of GEL1/GEL2 microsphere CPC and
microporous CPC6 (B).
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was observed. EDS analysis revealed that these crys-
tals consisted of calcium and phosphate which indi-
cated a recrystallization of the cement at these sites.
The separate gelatin microspheres showed already
deformations at day 1, slowly losing their spherical
shape and fusing into a network of gelatin particles
at week 4 and 6. After 12 weeks no separate gelatin
microspheres were distinguished anymore. The struc-
tures still visible with SEM were traced to accumula-
tions of PBS salts and some salts remaining from the
gelatin. Differences between the GEL1 and GEL 2
microspheres were visible especially at 4 weeks
where the remaining structures of the GEL2 micro-
spheres showed a smaller, more particle-like mor-
phology.
Supplementary microsphere degradation study
Figure 8 shows the % mass left after 1 day in degra-
dation medium using three types of gelatin and three
different pretreatment methods. The results showed
that the pretreatment method was important since
both PBS þ CaCl2 and PBS (pH 5 5.72) groups
degraded significantly slower than the PBS (pH 5 7.4)
group with all types of gelatin (Table II). A difference
between the PBS (pH 5 5.72) group and the PBS þ
CaCl2 group was observed with type B gelatin that
exhibited a higher mass loss with the PBS þ CaCl2
group. Furthermore it was observed that both type A
and type B gelatin degraded significantly faster than
the FG gelatin within all pretreatment groups.
Figure 3. pH decrease of surrounding medium (A) and mass loss (B) as a function of degradation time of the GEL1/
GEL2 microsphere CPC, microspheres, and microporous cement.
648 HABRAKEN ET AL.
Journal of Biomedical Materials Research Part A
Figures 9–11 depict SEM-micrographs of gelatin
type A, type B, and FG microspheres before and af-
ter pretreatment and after 1 day in enhanced degra-
dation medium. Before pretreatment only perfect
spheres were present, after pretreatment the spheres
were deformed within all groups. After 1 day in
enhanced degradation medium, microparticle struc-
ture was lost in the PBS (pH 5 7.4) groups, while
with the PBS þ CaCl2 and PBS (pH 5 5.72) groups
microparticles or a structure of elongated/connected
microparticle structures were still visible. Also, mor-
phological degradation was found to differ between
the various types of gelatin. Microspheres prepared
of FG gelatin maintained their microsphere structure
very well, while type A gelatin microspheres
showed deformations into an agglomerate structure
within all pretreatment groups. Type B gelatin was
intermediate, with the PBS þ CaCl2-group showing
a separate microparticle structure and the PBS (pH
5 5.72) group showing an agglomerate structure
consisting of thin, elongated microparticles.
DISCUSSION
In this study gelatin microspheres were added to
a microporous CPC to investigate the possibility of
these composite materials to serve as an injectable
bone substitute, and secondly as a possible creator
of macroporosity after gelatin degradation. For this
purpose, FG gelatin microspheres with different
crosslinking density were added to the cement and
subjected to physical/chemical characterization. An
in vitro degradation study with these composites
was performed in proteolytic degradation medium
to see whether macroporosity could be created. Fur-
thermore, to investigate the influence of physical
conditions inside the cement like pH and calcium
concentration on microsphere stability, a supplemen-
tary degradation study was performed. In this deg-
radation study also microspheres of cell-culture-
tested-gelatin type A and type B were investigated
and compared to the FG gelatin microspheres.
The physical characteristics of the cement with
added gelatin microspheres differed significantly
from the microporous cement. Initial setting time
showed a significant increase and final setting time
Figure 5. SEM-micrographs of GEL1 microsphere CPC
(left) and GEL1 microspheres (right) at t 5 1 day and 4, 6,
and 12 weeks (original magnification 3 100), arrows indi-
cate the presence of gelatin microsphere shells.
Figure 4. Compression strength (A) and E-modulus (B)
as a function of degradation time of the GEL1/GEL2
microsphere CPC and microporous cement.
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was not measurable. An explanation for this is that
the gelatin microspheres were added to the cement
in a swollen state to obtain a good distribution. The
water inside these microspheres contributed to
cement setting, leading to increased setting times.3
On the other hand, the addition of gelatin micro-
spheres to the cement resulted in improved injection
properties, as injection time increased for the gelatin
microsphere CPC when compared to microporous
cement. Differences in injectability were observed
between the GEL1 and GEL2 composite where
increased crosslinking of the gelatin microspheres
led to more stiffer structures.20 After cement setting,
SEM revealed that the microspheres inside the gela-
tin microsphere CPCs showed a structure of broken,
hollow spheres. It can be hypothesized that physical
bonds between the gelatin microspheres and sur-
rounding cement were responsible for this structure
as shrink stresses, arisen during drying, forced the
immobilized spheres to break.
The degradation experiment showed an initial
increase in mass for the gelatin microsphere CPCs at
day 1 and 3. This increase in mass was also observed
in a higher extent with the separate gelatin micro-
spheres and the microporous cement. An explana-
tion is the precipitation of PBS crystals on the out-
side of the cement samples and microspheres during
the experiment. The high increase observed with
separate gelatin microspheres was caused by a simi-
lar mechanism. Here, weight was measured after
gently removing the medium above the microsphere
gel and freeze-drying the microspheres. Because the
swollen gelatin microspheres contained about six
times their wt % of water, they also retained a PBS
precipitate that contributed to the weight of the sam-
ples. Rinsing the microspheres with demineralized
water before drying is not a solution, since this will
Figure 6. SEM-micrographs of GEL2 microsphere CPC
(left) and GEL2 microspheres (right) at t 5 1 day and 4, 6,
and 12 weeks (original magnification 3 100), arrows indi-
cate the presence of gelatin microsphere shells.
Figure 7. Close-up pictures of gelatin microspheres inside
the cement, showing precipitate onto/inside the gelatin
microspheres (arrows); (A) GEL1 3 days (original magnifi-
cation 3 250), (B) GEL1 2 weeks (original magnification 3
3000), (C) GEL1 6 weeks (original magnification 3 1000),
(D) GEL2 6 weeks (original magnification 3 1000).
Figure 8. Mass remaining at t 5 1 day of enhanced deg-
radation with Type A, Type B, and FG gelatin micro-
spheres after pretreatment in PBS with pH 5 7.4, 0.1M
CaCl2 or pH 5 5.72.
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greatly influence the mass of the microspheres them-
selves as degradation products dissolve during rins-
ing and microspheres will get lost.
The initial decrease in pHwas also observed in a pre-
vious experiment6 and is due to the release of acidic
products from the cement, while the microspheres
themselves only show aminimal decrease in pH.
The gelatin microsphere CPCs also showed a strik-
ing increase in mechanical strength within the first 7
days. This increase is due to the recrystallization of
the cement into hydroxyapatite (HA), which is well-
described in literature.3 In addition, the clear densifi-
cation of the cement observed with SEM is also most
likely caused by cement recrystallization. Because of
the biomimetic properties of the gelatin,12 the frac-
tured microspheres showed a shell of calcium phos-
phate (CaP) precipitate onto the surface forming a
strong bond between the cement and the gelatin.
Figure 9. SEM-micrographs of Type A gelatin microspheres before pretreatment (upper), after pretreatment in PBS with
pH 5 7.4, 0.1M CaCl2 or pH 5 5.72 (middle), and after t 5 1 day of enhanced degradation study (lower) (original magni-
fication 3 500).
TABLE II
Statistical Significance Samples Supplementary Degradation Study
Parameter Samples Significance
Pretreatment method Type A PBS (7.4) vs. type A PBS þ CaCl2 p < 0.001
Type A PBS (7.4) vs. type A PBS (5.72) p < 0.001
Type B PBS (7.4) vs. type B PBS þ CaCl2 p < 0.05
Type B PBS (7.4) vs. type B PBS (5.72) p < 0.001
Type B PBS þ CaCl2 vs. type B PBS (5.72) p < 0.001
Type FG PBS (7.4) vs. type FG PBS þ CaCl2 p < 0.001
Type FG PBS (7.4) vs. type FG PBS (5.72) p < 0.001
Type of gelatin Type A PBS (7.4) vs. type B PBS (7.4) p < 0.05
Type A PBS (7.4) vs. type FG PBS (7.4) p < 0.001
Type B PBS (7.4) vs. type FG PBS (7.4) p < 0.01
Type A PBS þ CaCl2 vs. type FG PBS þ CaCl2 p < 0.001
Type B PBS þ CaCl2 vs. type FG PBS þ CaCl2 p < 0.001
Type A PBS (5.72) vs. type FG PBS (5.72) p < 0.001
Type B PBS (5.72) vs. type FG PBS (5.72) p < 0.001
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Comparison of the current results with PLGA micro-
sphere CPCs in a previous experiment,6 the PLGA
microspheres were always present without a shell of
CaP precipitate. At later time points (>2 weeks)
even the formation of crystals inside the gelatin
microspheres was observed, indicating that the pores
formed by the microspheres can be filled with a pre-
cipitate.
At the end of the degradation test, the obtained
scaffold did not show an increase in macroporosity
or increased cement resorption. A first explanation
for these results is the occurrence of the discussed
CaP precipitates onto and inside gelatin micro-
spheres. The vol % of gelatin microspheres inside
the composite should be sufficient to form intercon-
nections between the microspheres. However, if CaP
is precipitating between two contacting micro-
spheres, no interconnection will be formed but a
shell of crystalline HA. Increasing the % of micro-
spheres inside the cement, can solve this problem
partially as the influence of the cement will be
smaller and more interconnections will be present.
On the other hand, precipitation will still occur and
the addition of more than 5 wt % of microspheres
greatly increases setting time and decreases mechan-
ical properties.3,6
Secondly, the weight loss of the GEL1 and GEL2
microsphere CPCs was very small when compared
to the microporous cement and did not exceed the
5 wt % of microspheres added initially. If the gelatin
microspheres inside the cement composite had
degraded as fast as the separate gelatin micro-
spheres, the composites should have shown a higher
decrease in mass and distinct morphological degra-
dation of the microspheres after 6–12 weeks. SEM-
pictures at these time points still showed the presence
of intact gelatin shells throughout the composite and
therefore it can be concluded that the microspheres
degraded slower inside these composites. An expla-
nation for the delayed degradation is binding/deac-
tivation of the enzyme to the CPC. Since gelatin
degrades by an enzymatic route, the calcium phos-
phate matrix of the gelatin microsphere CPC can
prevent the enzyme from entering the material. Col-
lagenase is prone to bind to CPC, which was proven
to have a protein-binding capacity.7,21,22 According
to Kremer et al.23 a suspension of HA crystals in
combination with free Ca2þ-ions (>0.5 mM) can
even induce an autolytic degradation of matrix
metalloprotease-1 (MMP-1, interstitial collagenase).
A decrease in pH, as observed with the gelatin micro-
sphere CPCs, also could have influenced collagenase
Figure 10. SEM-micrographs of Type B gelatin microspheres before pretreatment (upper), after pretreatment in PBS with
pH 5 7.4, 0.1M CaCl2 or pH 5 5.72 (middle), and after t 5 1 day of enhanced degradation study (lower) (original magni-
fication 3 500).
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activity. However, the optimal pH range for collage-
nase is 6.3–824 and individual pH values measured
during the test never dropped below 6.8.
From the supplementary microsphere degradation
test it can be concluded that a small pH decrease as
is present inside the microporous cement,6 delays
gelatin microsphere degradation by changing the
microsphere structure/stability. This is most likely
caused by the pH-dependent crosslink reaction of re-
sidual aldehyde groups after subjecting the micro-
spheres/composite to the degradation medium. In
this experiment gelatin microspheres were cross-
linked with glutaraldehyde to ensure structural sta-
bility of the spheres during cement mixing. The
amount of glutaraldehyde used (6.25 mM) and cross-
link time (1 h minimum) were just sufficient for
sphere stability because a fast degrading micro-
sphere was proposed to give a superior cement com-
posite. However, despite this low amount of cross-
linker, with the applied crosslink method free alde-
hyde groups were still present after microsphere
preparation as glutaraldehyde partially exists as
oligomers with multiple aldehyde chains.25 In aque-
ous conditions, for example the degradation me-
dium, these aldehyde chains can further react with
free amino groups, preferentially lysine or arginine
in the gelatin26 which leads to the formation of new
crosslinks, in particularly Schiff bases (R1R2C¼NR3,
with R3 5 alkylic or arylic).
27,28 As aldehyde groups
become more electrophilic at a lower pH,29 the mod-
est pH decrease must have accelerated these cross-
link reactions thereby stabilizing the microspheres
against proteolytic degradation. An approach to pre-
vent this delayed crosslink reaction is for example
the addition of an aldehyde reagent (inhibitor) to the
oil phase at the end of microsphere preparation. Gly-
cin13,30 is commonly used as it is a body-own sub-
stance. Also, the combined used of citric acid and
citric acic/glycin31 shows inhibition of the crosslink
reaction.
Next to covalent bonding of gelatin chains, nonco-
valent bonding also played a small role in the gelatin
microsphere CPC degradation as was observed in
the supplementary degradation test. Ca2þ-ions are
present inside the degradation medium due to the
dissolution of monetite and calcium carbonate. These
Ca2þ ions can bind to multiple sites in proteins,32
especially electrostatic interactions with the carboxy
groups33 from amino acids, like aspartate and gluta-
mate,26 can give stable bonds (Fig. 12). An example
of such a mechanism is given by Reinhardt et al.34
who observed that Ca2þ binding to motifs in Fibril-
lin-1 (an extracellular matrix protein) stabilizes the
structure against proteolytic degradation. In contrast
Figure 11. SEM-micrographs of Type FG gelatin microspheres before pretreatment (upper), after pretreatment in PBS
with pH 5 7.4, 0.1M CaCl2 or pH 5 5.72 (middle), and after t 5 1 day of enhanced degradation study (lower) (original
magnification 3 500).
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to this result, in this study the addition of Ca2þ-ions
led to an increase in degradation rate as was
observed with type B gelatin microspheres. Here, the
microspheres of the PBS þ CaCl2 group showed a
significant higher weight loss than the PBS (pH 5
5.72) group, whereas the pH during pretreatment of
both groups was the same. An explanation is that
with type B gelatin Ca2þ crosslinks existed that stabi-
lized the microparticle morphology but did not ham-
per microsphere degradation. The maintained micro-
particle structure possibly enhanced proteolytic deg-
radation because of the larger surface area of these
structures. The higher amount of carboxylic groups
of type B gelatin (100–115 mM) when compared to
type A gelatin (78–80 mM)35 was responsible for the
difference between the gelatin types, giving type B
gelatin a better Ca2þ-binding capacity. Regarding
this capacity, another explanation for the higher deg-
radation rate is a difference in enzyme activity.
Because Ca2þ serves as a cofactor for interstitial col-
lagenase,36,37 different authors have shown a reacti-
vation of collagenase/gelatinase in the presence of
3.7–10 mM of free Ca2þ.38,39 Therefore if the gelatin
also released Ca2þ during proteolytic degradation it
reactivated the enzyme, which would be more pro-
nounced with the type B gelatin.
Comparison of the three types of gelatin in the
supplementary degradation test revealed that in all
pretreatment groups type A and type B gelatin
microspheres degraded significantly faster than FG
gelatin microspheres. The main difference between
the two cell-culture tested gelatins and the FG gela-
tin is the bloom number that is significantly lower
with the FG gelatin. The bloom number is a measure
of gel strength of the gelatin35 and is proportional to
the average molecular weight of the chains. This
implies that FG gelatin has a significant lower molec-
ular weight and produces more gelatin chains per
unit of microsphere surface than type A or type B
gelatin. Therefore it can be hypothesized that with
type A and type B gelatin microspheres, enzymatic
cleavage of a single ‘‘large’’ gelatin chain has a
higher impact on microsphere degradation than with
the FG gelatin, which results in a faster degradation.
CONCLUSION
The prepared gelatin microsphere CPCs were easy
to handle with an initial setting time of less than
3 min. They possessed a compression strength of 6
30 MPa and a microsphere content of 43–44 vol %.
In vitro degradation showed a modest pH decrease,
a mechanical strength that remained constant in time
and a small decrease in mass. SEM-investigation of
the gelatin microsphere CPCs during the degrada-
tion test revealed little change in morphology, where
separate gelatin microspheres showed complete deg-
radation within the same time period. At the end of
the degradation test, no increase in macroporosity
was observed but even a clear densification of the
composite. Parameters that contributed to this phe-
nomenon were cement recrystallization inside/onto
the microspheres and a delayed gelatin degradation.
From the supplementary microsphere degradation
test it was concluded that the modest pH decrease
present inside the cement is a factor in the delayed
gelatin degradation. Also differences in degradation
rate between different types of gelatin were
observed. Overall, the gelatin microsphere CPC
showed good handling properties, though degrada-
tion characteristics should be further investigated to
generate a macroporous scaffold.
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